Fluzoparib
Fluzoparib (SHR3162) is an oral PARP inhibitor developed for cancer research. It demonstrates potent activity in vitro and has shown antitumor efficacy in vivo models of solid tumors, supporting its investigation for oncology applications.
Product Specifications
CAS Number
1358715-18-0
Product Name Alternative
Cancer, inhibit, Inhibitor, PARP1, PARP, Fluzoparib, Fuzuloparib, homologous recombination repair, HS 10160, HS10160, HS-10160, ovarian, poly ADP ribose polymerase, SHR 3162, SHR3162, SHR-3162
Field of Research
Epigenetics & Chromatin, Molecular Biology
Purity
98.00% (May vary between batches)
Solubility
DMSO:88.33 mg/mL (186.98 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.99 mM)
Smiles
Fc1ccc (Cc2n[nH]c (=O) c3ccccc23) cc1C (=O) N1CCn2nc (nc2C1) C (F) (F) F
Molecular Formula
C22H16F4N6O2
Molecular Weight
472.4
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
15951116 3x 1.0 µg
Ces2h sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
MBS7167357 Inquire
Rabbit anti-Escherichia coli O1:K1/APEC ZAPA Polyclonal Antibody
Sign In for Pricing
View Details 
abx197590 96 Tests
Mouse Protein Disulfide-Isomerase / PDI (P4HB) CLIA Kit
Sign In for Pricing
View Details RC237098 10 µg
C22orf25 (TANGO2) (NM_001283116) Human Tagged ORF Clone
Sign In for Pricing
View Details